solutions for the pharmaceutical industry

hazardous waste management

You know the deal, to comply with stringent regulations hazardous waste has to be handled through specialized channels. To simplify this process, SUEZ has developed the best solutions to sort and prepare hazardous waste within our customers sites.


With a dedicated on-site organization, SUEZ provides waste and hazardous waste characterization; containment and disposal; waste treatment and recovery, while ensuring people’s safety and environment preservation.


SUEZ chemical waste specialists have a comprehensive knowledge of waste and hazardous composition and performance, a first and crucial step to define the most adequate solutions and improve recycling and recovery rates.


SUEZ hazardous waste management services include:

  • Onsite sorting & pre-treatment
  • Logistics management optimization
  • Alternative transportation
  • Waste co-processing
  • Waste treatment
  • Hazardous waste recovery
  • Complete traceability with real time reporting 

are you ready?

we offer you the best available solutions to sort and prepare your waste on site

With SUEZ’ expertise, you will benefit from:


  • A dedicated on site organization, lead by a hazardous waste chemical specialist 
  • An on site sorting and grouping of your hazardous waste In full compliance with  Health and Safety guidelines 
  • A European waste flow to find the best recovery solution available using the SUEZ network of assets and also external partnerships if necessary. 
  • A full efficient and committed plan for productivity.
  • A complete traceability with a real time reporting, based on an IT system built with our customers

SUEZ
Tour CB21
16, place de l’Iris
92040 Paris La Défense Cedex 
Tel: +33 (0)1 58 81 20 00
Fax: +33 (0)1 58 81 25 00
www.suez.com

contact.industry@suez.com
www.suezwatertechnologies.com

CONTACT US

we can provide the best solutions to sort and prepare waste on-site

Go to article: Home | Invest in TechGo to article: In this issueGo to article: Gerteis Company InsightGo to article: GerteisGo to article: ContentsGo to article: DJAGo to article: NewsGo to article: MedelpharmGo to article: Biotech M&A: will the 2018 surge last?Go to article: NSFGo to article: Can the gene and cell therapy revolution scale up?Go to article: Haselmeier GmbH Company InsightGo to article: Haselmeier GmbH Go to article: Gut instinct: how common drugs affect the microbiomeGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Tracing the story of mumps: a timelineGo to article: Molnar Company InsightGo to article: MolnarGo to article: Inside Swiss pharma: the ideal environment for successGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: MoehsGo to article: Could digital tech unlock billions in savings for pharma companies?Go to article: EcocoolGo to article: CRISPR: a seismic shift in gene editingGo to article: Mestra AG (Endress + Hauser)Go to article: EventsGo to article: Pfanstiehl Inc Company InsightGo to article: Pfanstiehl Inc.Go to article: Next issueGo to article: Niconex Medical LtdGo to article: Alpex Pharma SAGo to article: Pall Biotech Company InsightGo to article: Pall BiotechGo to article: AtoZ-CRO GmbHGo to article: WIKA - Disaster preventionGo to article: Bea TechnologiesGo to article: BaxterGo to article: SuezGo to article: Raland Compliance Partners